These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 33709472)
1. Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease. Lee HJ; Jeon SG; Kim J; Kang RJ; Kim SM; Han KM; Park H; Kim KT; Sung YM; Nam HY; Koh YH; Song M; Suk K; Hoe HS Aging Cell; 2021 Mar; 20(3):e13332. PubMed ID: 33709472 [TBL] [Abstract][Full Text] [Related]
2. L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD. Lee HJ; Nam J; Hwang JW; Park JH; Jeong YJ; Jang JY; Kim SJ; Jo AR; Hoe HS Mol Brain; 2024 Apr; 17(1):21. PubMed ID: 38685105 [TBL] [Abstract][Full Text] [Related]
3. A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease. Modi KK; Jana A; Ghosh S; Watson R; Pahan K PLoS One; 2014; 9(8):e103606. PubMed ID: 25089827 [TBL] [Abstract][Full Text] [Related]
4. The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta. Chae S; Lee HJ; Lee HE; Kim J; Jeong YJ; Lin Y; Kim HY; Leriche G; Ehrlich RS; Lingl SC; Seo MD; Lee YH; Yang J; Kim JI; Hoe HS J Neuroinflammation; 2024 Aug; 21(1):200. PubMed ID: 39129007 [TBL] [Abstract][Full Text] [Related]
5. A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease. Yao Y; Muench M; Alle T; Zhang B; Lucero B; Perez-Tremble R; McGrosso D; Newman M; Gonzalez DJ; Lee VM; Ballatore C; Brunden KR Alzheimers Dement; 2024 Jul; 20(7):4540-4558. PubMed ID: 38884283 [TBL] [Abstract][Full Text] [Related]
6. Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD. Han KM; Kang RJ; Jeon H; Lee HJ; Lee JS; Park H; Gak Jeon S; Suk K; Seo J; Hoe HS Cells; 2020 Jul; 9(7):. PubMed ID: 32660121 [TBL] [Abstract][Full Text] [Related]
7. Profiling tyrosine kinase inhibitors as AD therapeutics in a mouse model of AD. Lee HJ; Hwang JW; Park JH; Jeong YJ; Jang JY; Hoe HS Mol Brain; 2023 Aug; 16(1):63. PubMed ID: 37580778 [TBL] [Abstract][Full Text] [Related]
8. NaoXinTong Capsule ameliorates memory deficit in APP/PS1 mice by regulating inflammatory cytokines. Wang X; Yin Z; Cao P; Zheng S; Chen Y; Yu M; Liao C; Zhang Z; Duan Y; Han J; Zhang S; Yang X Biomed Pharmacother; 2021 Jan; 133():110964. PubMed ID: 33197761 [TBL] [Abstract][Full Text] [Related]
9. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease. Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling. Lee HJ; Hoe HS Pharmacol Res; 2023 Apr; 190():106725. PubMed ID: 36907286 [TBL] [Abstract][Full Text] [Related]
11. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease. Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984 [TBL] [Abstract][Full Text] [Related]
12. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease. Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414 [TBL] [Abstract][Full Text] [Related]
13. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus. Zhang ZX; Zhao RP; Wang DS; Li YB Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086 [TBL] [Abstract][Full Text] [Related]
14. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology. Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311 [TBL] [Abstract][Full Text] [Related]
15. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Liu HL; Zhao G; Zhang H; Shi LD Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591 [TBL] [Abstract][Full Text] [Related]
16. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction. Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924 [TBL] [Abstract][Full Text] [Related]
18. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL; Tung YC; Liu F; Gong CX; Iqbal K Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice. Gao L; Tian S; Gao H; Xu Y J Mol Neurosci; 2013 Sep; 51(1):138-47. PubMed ID: 23345083 [TBL] [Abstract][Full Text] [Related]
20. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles. Chu J; Li JG; Praticò D PLoS One; 2013; 8(8):e70991. PubMed ID: 23951061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]